CoChat

Recent Advancements in the Atopic Dermatitis Mechanism

Open access
Savva, Maria, Papadopoulos, Nikolaos G, Gregoriou, Stamatis, Katsarou, Spyridoula, Papapostolou, Niki, Makris, Michael, Xepapadaki, Paraskevi · 2024 · Frontiers in Bioscience-Landmark

The DOI matches its Crossref record; 159 of the 159 references it cites were found in a registry or an index.

Abstract

Atopic dermatitis (AD) is a recurrent, chronic, inflammatory, itchy skin disorder that affects up to 20% of the pediatric population and 10% of the adult population worldwide. Onset typically occurs early in life, and although cardinal disease features are similar across all ages, different age groups and ethnicities present distinct clinical characteristics. The disease imposes a significant burden in all health-related quality of life domains, both in children and adults, and a substantial economic cost both at individual and national levels. The pathophysiology of AD includes a complex and multifaceted interplay between the impaired dysfunctional epidermal barrier, genetic predisposition, and environmental contributors, such as chemical and/or biological pollutants and allergens, in the context of dysregulated TH2 and TH17 skewed immune response. Regarding the genetic component, the loss of function mutations encoding structural proteins such as filaggrin, a fundamental epidermal protein, and the more recently identified variations in the epidermal differentiation complex are well-established determinants resulting in an impaired skin barrier in AD. More recently, epigenetic factors have facilitated AD development, including the dysbiotic skin microbiome and the effect of the external exposome, combined with dietary disorders. Notably, the interleukin (IL)-31 network, comprising several cell types, including macrophages, basophils, and the generated cytokines involved in the pathogenesis of itch in AD, has recently been explored. Unraveling the specific AD endotypes, highlighting the implicated molecular pathogenetic mechanisms of clinically relevant AD phenotypes, has emerged as a crucial step toward targeted therapies for personalized treatment in AD patients. This review aims to present state-of-the-art knowledge regarding the multifactorial and interactive pathophysiological mechanisms in AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.31083/j.fbl2902084

Cites

159 of 159 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Janus kinase/signal transducer and activator of transcription (JAK/STAT) inhibitors in atopic dermatitis (AD) inflammatory pathway. IL, interleukin; IFNγ , interferonγ ; TSLP, thymic stromal lymphopoietin.
Fig. 1 Janus kinase/signal transducer and activator of transcription (JAK/STAT) inhibitors in atopic dermatitis (AD) inflammatory pathway. IL, interleukin; IFNγ , interferonγ ; TSLP, thymic stromal lymphopoietin.CC-BY · From the PDF
Image 2
CC-BY · From the PDF
Fig. 3 The interplay among different pathogenic factors that contribute to the pathogenesis of atopic dermatitis. IL, interleukin; TSLP, thymic stromal lymphopoietin; IDEC, inflammatory dendritic epidermal cell.
Fig. 3 The interplay among different pathogenic factors that contribute to the pathogenesis of atopic dermatitis. IL, interleukin; TSLP, thymic stromal lymphopoietin; IDEC, inflammatory dendritic epidermal cell.CC-BY · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

17 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 159 references

Cited by

See all 65

Metadata

Authors
Savva, M., Papadopoulos, N. G., Gregoriou, S., Katsarou, S., Papapostolou, N., Makris, M., & Xepapadaki, P.
Affiliations
  • National and Kapodistrian University of Athens (GR)
  • Department of Dermatology and Venereology, Faculty of Medicine, National and Kapodistrian University of Athens, Andreas Sygros Hospital, 16121 Athens, Greece
Corresponding author
Savva, Maria
Venue
Frontiers in Bioscience-Landmark
Publisher
IMR Press
Published
2024-02-22
Volume
29
Issue
2
Pages
84-84
ISSN
  • 2768-6698 (ISSN-L)
  • 2768-6701
OpenAlex
W4392106846
Cited by
53
References
159
Citations by year
2026: 18 · 2025: 26 · 2024: 9
FWCI
4.14
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Bioscience-Landmark (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
  • Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
Keywords
atopic dermatitis, pathophysiology, skin barrier dysfunction, filaggrin, epidermal differentiation complex, genetic susceptibility, epigenetics, skin microbiome, exposome, dietary factors, IL-31, pruritus, endotypes, pediatric atopic dermatitis, quality of life, economic burden
MeSH terms
Adult, Child, Dermatitis, Atopic, Humans, Quality of Life, Skin, Cytokines, Genetic Predisposition to Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Recent Advancements in the Atopic Dermatitis Mechanism. https://app.cochat.ai/papers/10.31083/j.fbl2902084
The paper
Savva, M., Papadopoulos, N. G., Gregoriou, S., Katsarou, S., Papapostolou, N., Makris, M., & Xepapadaki, P. (2024). Recent Advancements in the Atopic Dermatitis Mechanism. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/j.fbl2902084

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.